Rize Oncology Statistics

Total Valuation

Rize Oncology has a market cap or net worth of CAD 2.27 million. The enterprise value is 600,400.

Market Cap	2.27M
Enterprise Value	600,400

Important Dates

The next estimated earnings date is Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Rize Oncology has 75.74 million shares outstanding. The number of shares has decreased by -16.52% in one year.

Current Share Class	n/a
Shares Outstanding	75.74M
Shares Change (YoY)	-16.52%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	87.97%
Owned by Institutions (%)	n/a
Float	9.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.42
P/TBV Ratio	1.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.76
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.35

Current Ratio	14.35
Quick Ratio	13.98
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -44.40% and return on invested capital (ROIC) is -29.67%.

Return on Equity (ROE)	-44.40%
Return on Assets (ROA)	-28.28%
Return on Invested Capital (ROIC)	-29.67%
Return on Capital Employed (ROCE)	-53.10%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.33% in the last 52 weeks. The beta is 2.37, so Rize Oncology's price volatility has been higher than the market average.

Beta (5Y)	2.37
52-Week Price Change	-33.33%
50-Day Moving Average	0.09
200-Day Moving Average	0.07
Relative Strength Index (RSI)	6.58
Average Volume (20 Days)	1,253

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-847,517
Pretax Income	-792,687
Net Income	-792,687
EBITDA	n/a
EBIT	-847,517
Earnings Per Share (EPS)	-0.02

Full Income Statement

Balance Sheet

The company has 1.67 million in cash and n/a in debt, giving a net cash position of 1.67 million or 0.02 per share.

Cash & Cash Equivalents	1.67M
Total Debt	n/a
Net Cash	1.67M
Net Cash Per Share	0.02
Equity (Book Value)	1.60M
Book Value Per Share	0.04
Working Capital	1.60M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-670,399
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Rize Oncology does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	16.52%
Shareholder Yield	16.52%
Earnings Yield	-34.88%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a